Peringatan Keamanan

The intramuscular LD50 in rats is approximately 105 mg/kg; intraperitoneally 140 mg/kg. The intraperitoneal LD80 in mice is approximately 125 mg/kg. Dimercaprol has been shown in animal experiments to increase brain deposition of arsenite, organic mercury compounds and increase the toxicity of cadmium and lead. Dimercaprol has been shown to induce seizure in animal studies and also is nephrotoxic.

Dimercaprol

DB06782

small molecule approved

Deskripsi

Dimercaprol is a traditional chelating agent developed by British biochemists at Oxford University during World War II. It was developed as an experimental antidote against the arsenic-based poison gas Lewisite. It has been used clinically since 1949 in arsenic, cadmium and mercury poisoning. In addition, it has in the past been used for the treatment of Wilson's disease, a genetic disorder in which the body tends to retain copper. Dimercaprol has toxic potential, and its use may be followed by a variety of adverse effects.

Struktur Molekul 2D

Berat 124.225
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) The drug has a short half life.
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

After intra-muscular injection.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Urine.

Interaksi Obat

755 Data
Nitroprusside Dimercaprol may increase the nephrotoxic activities of Nitroprusside.
Iron Dextran Dimercaprol may increase the nephrotoxic activities of Iron Dextran.
Iron Dimercaprol may increase the nephrotoxic activities of Iron.
Ferumoxytol Dimercaprol may increase the nephrotoxic activities of Ferumoxytol.
Prussian blue Dimercaprol may increase the nephrotoxic activities of Prussian blue.
Ferric carboxymaltose Dimercaprol may increase the nephrotoxic activities of Ferric carboxymaltose.
Iron sucrose Dimercaprol may increase the nephrotoxic activities of Iron sucrose.
Ferric pyrophosphate Dimercaprol may increase the nephrotoxic activities of Ferric pyrophosphate.
Ferric ammonium citrate Dimercaprol may increase the nephrotoxic activities of Ferric ammonium citrate.
Ferumoxsil Dimercaprol may increase the nephrotoxic activities of Ferumoxsil.
Ferumoxides Dimercaprol may increase the nephrotoxic activities of Ferumoxides.
Ferric sulfate Dimercaprol may increase the nephrotoxic activities of Ferric sulfate.
Ferrous bisglycinate Dimercaprol may increase the nephrotoxic activities of Ferrous bisglycinate.
Gleptoferron Dimercaprol may increase the nephrotoxic activities of Gleptoferron.
Ferric oxide Dimercaprol may increase the nephrotoxic activities of Ferric oxide.
Perflubutane Dimercaprol may increase the nephrotoxic activities of Perflubutane.
Ferrous sulfate anhydrous Dimercaprol may increase the nephrotoxic activities of Ferrous sulfate anhydrous.
Sodium feredetate Dimercaprol may increase the nephrotoxic activities of Sodium feredetate.
Ferric hydroxide Dimercaprol may increase the nephrotoxic activities of Ferric hydroxide.
Ferrous chloride Dimercaprol may increase the nephrotoxic activities of Ferrous chloride.
Ferric cation Dimercaprol may increase the nephrotoxic activities of Ferric cation.
Ferrous gluconate Dimercaprol may increase the nephrotoxic activities of Ferrous gluconate.
Ferrous succinate Dimercaprol may increase the nephrotoxic activities of Ferrous succinate.
Ferrous fumarate Dimercaprol may increase the nephrotoxic activities of Ferrous fumarate.
Tetraferric tricitrate decahydrate Dimercaprol may increase the nephrotoxic activities of Tetraferric tricitrate decahydrate.
Ferric oxyhydroxide Dimercaprol may increase the nephrotoxic activities of Ferric oxyhydroxide.
Ferric maltol Dimercaprol may increase the nephrotoxic activities of Ferric maltol.
Iron isomaltoside 1000 Dimercaprol may increase the nephrotoxic activities of Iron isomaltoside 1000.
Iron polymaltose Dimercaprol may increase the nephrotoxic activities of Iron polymaltose.
Technetium Tc-99m oxidronate Dimercaprol may decrease effectiveness of Technetium Tc-99m oxidronate as a diagnostic agent.
Cyclosporine Cyclosporine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Icosapent Icosapent may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefotiam Cefotiam may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Mesalazine Mesalazine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefmenoxime Cefmenoxime may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefmetazole Cefmetazole may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Pamidronic acid Pamidronic acid may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Tenofovir disoproxil Tenofovir disoproxil may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Indomethacin Indomethacin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cidofovir Cidofovir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefpiramide Cefpiramide may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Ceftazidime Ceftazidime may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Loracarbef Loracarbef may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefalotin Cefalotin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Nabumetone Nabumetone may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Ketorolac Ketorolac may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Tenoxicam Tenoxicam may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Celecoxib Celecoxib may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefotaxime Cefotaxime may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Tolmetin Tolmetin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Foscarnet Foscarnet may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Rofecoxib Rofecoxib may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Piroxicam Piroxicam may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Methotrexate Methotrexate may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cephalexin Cephalexin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Fenoprofen Fenoprofen may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Valaciclovir Valaciclovir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Valdecoxib Valdecoxib may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Diclofenac Diclofenac may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Sulindac Sulindac may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Bacitracin Bacitracin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Amphotericin B Amphotericin B may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cephaloglycin Cephaloglycin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Flurbiprofen Flurbiprofen may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Adefovir dipivoxil Adefovir dipivoxil may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Pentamidine Pentamidine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Etodolac Etodolac may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Mefenamic acid Mefenamic acid may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Acyclovir Acyclovir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Naproxen Naproxen may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Sulfasalazine Sulfasalazine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Phenylbutazone Phenylbutazone may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Meloxicam Meloxicam may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Carprofen Carprofen may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefaclor Cefaclor may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Diflunisal Diflunisal may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Tacrolimus Tacrolimus may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Ceforanide Ceforanide may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Salicylic acid Salicylic acid may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Meclofenamic acid Meclofenamic acid may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Acetylsalicylic acid Acetylsalicylic acid may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Carboplatin Carboplatin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Oxaprozin Oxaprozin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Ketoprofen Ketoprofen may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Balsalazide Balsalazide may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Ibuprofen Ibuprofen may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefditoren Cefditoren may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Atazanavir Atazanavir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Colistimethate Colistimethate may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefuroxime Cefuroxime may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefapirin Cefapirin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefadroxil Cefadroxil may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefprozil Cefprozil may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Ceftriaxone Ceftriaxone may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Olsalazine Olsalazine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Lumiracoxib Lumiracoxib may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefamandole Cefamandole may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefazolin Cefazolin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefonicid Cefonicid may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Cefoperazone Cefoperazone may decrease the excretion rate of Dimercaprol which could result in a higher serum level.

Target Protein

Arsenic
Cadmium
Mercury
Amyloid-beta precursor protein APP

Referensi & Sumber

Synthesis reference: Peppel, W.J. and Signaigo, F.K.; U.S. Patent 2,402,665; June 25,1946; assigned to E.I. du Pont de Nemwrs & Company.
Artikel (PubMed)
  • PMID: 19596747
    Walshe JM: The conquest of Wilson's disease. Brain. 2009 Aug;132(Pt 8):2289-95. doi: 10.1093/brain/awp149. Epub 2009 Jul 13.
  • PMID: 20003760
    Boscolo M, Antonucci S, Volpe AR, Carmignani M, Di Gioacchino M: Acute mercury intoxication and use of chelating agents. J Biol Regul Homeost Agents. 2009 Oct-Dec;23(4):217-23.
  • PMID: 20717537
    Flora SJ, Pachauri V: Chelation in metal intoxication. Int J Environ Res Public Health. 2010 Jul;7(7):2745-88. doi: 10.3390/ijerph7072745. Epub 2010 Jun 28.
  • PMID: 14754439
    Andersen O: Chemical and biological considerations in the treatment of metal intoxications by chelating agents. Mini Rev Med Chem. 2004 Jan;4(1):11-21.

Contoh Produk & Brand

Produk: 3 • International brands: 4
Produk
  • Bal
    Injection • 100 mg/1mL • Intramuscular • US • Approved
  • BAL in Oil
    Injection • 100 mg/1mL • Intramuscular • US • Approved
  • Bal In Oil 3ml Ampules/10
    Solution • 100 mg / mL • Intramuscular • Canada • Approved
International Brands
  • Bal In Oil Injection — Taylor Pharmaceuticals
  • Dimaval — Heyl
  • Dimercaprol — Akorn
  • TechneScan DMSA — Mallinckrodt

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul